Log In
BCIQ
Print this Print this
 

LAPS CA Exendin-4, efpeglenatide (SAR439977) (formerly HM11260C)

Also known as: LAPS-Exendin4

  Manage Alerts
Collapse Summary General Information
Company Hanmi Pharmaceutical Co. Ltd.
DescriptionGlucagon-like peptide-1 receptor (GLP-1R; GLP1R) agonist
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$4,340.6M

$440.6M

$3,900.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/05/2015

$4,340.6M

$440.6M

$3,900.0M

Get a free BioCentury trial today